Journal

One vial of reta, before the brand exists

Reta is retatrutide. Some chats type GLP-3. That is slang, not a hormone named GLP-3. Retatrutide hits GIP, GLP-1, and glucagon receptors. Same vial either way.

Lilly is the company studying it. The FDA has not approved it. Lilly has said it plans to file in the first quarter of 2027. Until that happens, there is no brand-name pen on a pharmacy shelf. The thing people are actually buying online, when they buy it, is a research vial.

Ours start at one 5mg vial for $35. Then 10mg for $50, 15mg for $60, 20mg for $75, 30mg for $110, 40mg for $140, and 60mg for $200. Buy one or as many as you like. At least 99% pure. Fill within 10% of the label, so a 10mg vial is 9mg to 11mg.

Lilly also opened a narrow early-access door in August 2026 for some patients who cannot join a trial. That is Lilly picking patients. It is not a product you order like a normal prescription, and it is not this vial.

The reta sizes. Tirz and reta prices next to each other.

Research vials. 21 and older. Not for people or animals. Not medical advice.